(2026). Functional connectome metrics reveal distinct prognostic subtypes in two Phase 3 gantenerumab trials. Alzheimer's & Dementia: Translational Research & Clinical Interventions.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Functional Connectome Metrics Reveal Distinct Prognostic Subtypes in Two Phase 3 Gantenerumab Trials."
Alzheimer's & Dementia: Translational Research & Clinical Interventions 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Functional Connectome Metrics Reveal Distinct Prognostic Subtypes in Two Phase 3 Gantenerumab Trials."
Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.